Stocks
Eli Lilly and Company (LLY) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 28.4% | 30.3% | 25.1% | 33.8% | 42.9% | 45.9% | ||
| Changes by years, y/y, % | -8pp | +2pp | -5pp | +9pp | +9pp | +3.4% | |||
Eli Lilly and Company. EBITDA margin, %
Eli Lilly and Company. EBITDA margin, changes, pp
Eli Lilly and Company (LLY) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 32.7% | 48.2% | 44.8% | 43.5% | 47.3% | 45.9% | |
| Changes by years, y/y, % | -3pp | +12pp | +25pp | +1pp | +15pp | |||
| Changes by quarters, q/q, % | -10pp | +16pp | -3pp | -1pp | +4pp | |||
